RaQualia Pharma Inc
TSE:4579
RaQualia Pharma Inc
Revenue
RaQualia Pharma Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
RaQualia Pharma Inc
TSE:4579
|
Revenue
¥1.9B
|
CAGR 3-Years
20%
|
CAGR 5-Years
21%
|
CAGR 10-Years
24%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Revenue
¥4.2T
|
CAGR 3-Years
9%
|
CAGR 5-Years
19%
|
CAGR 10-Years
10%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Revenue
¥1.5T
|
CAGR 3-Years
16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
4%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Revenue
¥2T
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
4%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Revenue
¥1.1T
|
CAGR 3-Years
12%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
|
Astellas Pharma Inc
TSE:4503
|
Revenue
¥1.9T
|
CAGR 3-Years
15%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
See Also
What is RaQualia Pharma Inc's Revenue?
Revenue
1.9B
JPY
Based on the financial report for Dec 31, 2023, RaQualia Pharma Inc's Revenue amounts to 1.9B JPY.
What is RaQualia Pharma Inc's Revenue growth rate?
Revenue CAGR 10Y
24%
Over the last year, the Revenue growth was -35%. The average annual Revenue growth rates for RaQualia Pharma Inc have been 20% over the past three years , 21% over the past five years , and 24% over the past ten years .